Table 1.
Characteristics of the included 4 studies.
| Authors | Study design | Location | Source of strains | Reference standard | Ebola virus | Blinded review or interpretation | The characteristics of the controls | |||
|---|---|---|---|---|---|---|---|---|---|---|
| TP | FP | FN | TN | |||||||
| James Pettitt [19] (2015) | Prospective cohort study | America | 402 semen | Ebola Zaire target 1 (EZ1) and major groove binder RT-PCR | 94 | 0 | 4 | 308 | Yes | Samples were collected from uninfected individuals |
| Amy James Loftis [20] (2016) | Prospective cohort study | America | 80 semen | Traditional PCR | 30 | 0 | 0 | 50 | Yes | Samples were procured commercially from healthy donors |
| Rafael Van den Bergh [14] (2016) | Prospective cohort study | Belgium | 218 semen | A routine in-house Ebola PCR | 18 | 8 | 0 | 192 | Yes | Suspected EVD patients for routine diagnosis between May 2 and July 4, 2015 |
| Amanda E. Semper [15] (2016) | Prospective cohort study | England | 218 WB | Reverse transcription PCR, Trombley | 22 | 8 | 0 | 181 | Yes | Residual diagnostic specimens remaining after clinical testing from suspected or confirmed EVD patients between April 1 and July 20, 2015 |
| Amanda E. Semper [15] (2016) | Prospective cohort study | England | 64 semen | Reverse transcription PCR, Trombley | 20 | 0 | 0 | 44 | Yes | Residual diagnostic samples remaining after clinical testing from suspected or confirmed EVD patients between March 7 and July 20, 2015, some of which had been frozen before use |
TP: true positive; TN: true negative; FP: false positive; FN: false negative; WB: whole blood.